60 KRW
3.58 B KRW
56.23 B KRW
52.95 M
About PHARMICELL
Sector
CEO
Hyun-Soo Kim
Headquarters
Seoul
Website
Founded
1968
ISIN
KR7005690003
FIGI
BBG000BGVS78
Pharmicell Co., Ltd. is engaged in the development of stem cell based pharmaceuticals and technologies. It operates through the Bio and Chemical Business Divisions. The Bio division provides cosmetics, cell for researches, medical testing equipment, and others. The Chemical division offers nucleoside, agricultural pesticides, fire retardant materials, and others. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 005690 is 8,250 KRW — it has increased by 3.38% in the past 24 hours. Watch PHARMICELL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PHARMICELL stocks are traded under the ticker 005690.
005690 stock has risen by 15.87% compared to the previous week, the month change is a 70.45% rise, over the last year PHARMICELL has showed a 46.28% increase.
005690 reached its all-time high on Apr 10, 2018 with the price of 26,350 KRW, and its all-time low was 260 KRW and was reached on May 11, 2004. View more price dynamics on 005690 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
005690 stock is 8.92% volatile and has beta coefficient of 1.57. Track PHARMICELL stock price on the chart and check out the list of the most volatile stocks — is PHARMICELL there?
Today PHARMICELL has the market capitalization of 495.03 B, it has increased by 17.38% over the last week.
Yes, you can track PHARMICELL financials in yearly and quarterly reports right on TradingView.
005690 net income for the last quarter is 714.03 M KRW, while the quarter before that showed 2.83 B KRW of net income which accounts for −74.75% change. Track more PHARMICELL financial stats to get the full picture.
No, 005690 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 136.00 employees. See our rating of the largest employees — is PHARMICELL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMICELL EBITDA is 4.35 B KRW, and current EBITDA margin is 6.74%. See more stats in PHARMICELL financial statements.
Like other stocks, 005690 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMICELL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMICELL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMICELL stock shows the buy signal. See more of PHARMICELL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.